Urology & Nephrology News, Treatment Studies | Renal, Urology …
New data presented at Kidney Week 2024 expand what is known about the beneficial effects of SGLT2 inhibitors and GLP-1 receptor agonists in patients with chronic kidney disease.
News Archive - Renal and Urology News
Nov 20, 2024 · A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for metastatic bladder cancer.
Lupus Nephritis Urine Test May Aid Diagnosis, Guide Treatment
1 day ago · A noninvasive urinary biomarker panel predicts lupus nephritis activity and response better than proteinuria, and, if further validated, may aid diagnosis and gauge treatment …
Jardiance Approved for Adults With Chronic Kidney Disease
Sep 25, 2023 · The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of sustained decline in estimated glomerular filtration rate …
Vibegron Treats Overactive Bladder in Men With Benign Prostatic ...
Jun 17, 2024 · Vibegron reduces storage symptoms of overactive bladder (OAB) in men treated for benign prostatic hyperplasia (BPH), data show. In a phase 3 trial of 1105 patients with OAB …
News And Features - Renal and Urology News
New data presented at Kidney Week 2024 expand what is known about the beneficial effects of SGLT2 inhibitors and GLP-1 receptor agonists in patients with chronic kidney disease.
Real-World Data Support Robot-Assisted Radical Cystectomy for …
5 days ago · Real-world data support the effectiveness of robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) relative to open radical cystectomy for …
The Changing Treatment Paradigm for IgAN - Renal and Urology …
May 12, 2023 · Although immunoglobulin A nephropathy (IgAN) remains incurable, clinicians can now offer patients treatments that can reduce proteinuria and potentially improve outcomes.. …
Novel Aldosterone Synthase Inhibitor Could Enhance CKD Therapy
Jan 19, 2024 · The novel selective aldosterone synthase inhibitor BI 690517 (up to 10 mg daily) with concurrent renin-angiotensin-system (RAS) inhibition, with or without the SGLT2 inhibitor …
Semaglutide Improves Kidney Outcomes in High-Risk Patients
May 28, 2024 · References: Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type diabetes. N Eng J Med.Published online May 24, …